Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 09:03 am EDT
Inhibitor Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 315,044 compared to USD 635,500 a year ago. Net loss was USD 314,894 compared to USD 632,691 a year ago. For the half year, operating loss was USD 700,486 compared to USD 1.427 million a year ago. Net loss was USD 699,311 compared to USD 1.418 million a year ago.